0001654954-18-006742.txt : 20180618 0001654954-18-006742.hdr.sgml : 20180618 20180618163026 ACCESSION NUMBER: 0001654954-18-006742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180614 FILED AS OF DATE: 20180618 DATE AS OF CHANGE: 20180618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KENNEDY WILLIAM JAMES CENTRAL INDEX KEY: 0001448888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 18904992 MAIL ADDRESS: STREET 1: C/O XTL BIOPHARMACEUTICALS LTD STREET 2: 711 EXECUTIVE BLVD., SUITE Q CITY: VALLEY COTTAGE STATE: NY ZIP: 10989 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 section16.xml FORM-4 X0306 4 2018-06-14 0001001316 TG THERAPEUTICS, INC. TGTX 0001448888 KENNEDY WILLIAM JAMES 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 true false false false COMMON STOCK 2018-06-14 4 S false 25071 13.45 D 60330 D Includes shares of restricted Common Stock, which vest over various time periods. /s/ William Kennedy 2018-06-18